Percutaneously Delivered Aortic Valve R&D: Edwards Weighs Trial Options
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will decide whether to continue in-house development of a minimally invasive heart valve or to merge its R&D program with that of Percutaneous Valve Technology, Inc